Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.21M Buy
17,304
+111
+0.6% +$20.6K 1.22% 22
2025
Q1
$3.6M Sell
17,193
-6
-0% -$1.26K 1.49% 20
2024
Q4
$3.06M Buy
17,199
+172
+1% +$30.6K 1.26% 22
2024
Q3
$3.36M Buy
17,027
+17
+0.1% +$3.36K 1.4% 22
2024
Q2
$2.92M Buy
17,010
+149
+0.9% +$25.6K 1.31% 22
2024
Q1
$3.07M Buy
16,861
+13,319
+376% +$2.43M 1.39% 21
2023
Q4
$549K Buy
3,542
+22
+0.6% +$3.41K 0.27% 86
2023
Q3
$525K Buy
3,520
+1,417
+67% +$211K 0.28% 87
2023
Q2
$283K Sell
2,103
-3,203
-60% -$432K 0.15% 113
2023
Q1
$846K Buy
5,306
+36
+0.7% +$5.74K 0.44% 67
2022
Q4
$852K Sell
5,270
-3,921
-43% -$634K 0.45% 67
2022
Q3
$1.23M Buy
9,191
+3,991
+77% +$536K 0.37% 74
2022
Q2
$796K Buy
5,200
+34
+0.7% +$5.21K 0.39% 67
2022
Q1
$838K Buy
5,166
+19
+0.4% +$3.08K 0.35% 67
2021
Q4
$697K Buy
5,147
+1,081
+27% +$146K 0.28% 75
2021
Q3
$439K Buy
4,066
+21
+0.5% +$2.27K 0.2% 94
2021
Q2
$456K Sell
4,045
-630
-13% -$71K 0.21% 92
2021
Q1
$506K Buy
+4,675
New +$506K 0.25% 80
2020
Q3
Sell
-2,193
Closed -$215K 130
2020
Q2
$215K Buy
+2,193
New +$215K 0.13% 123
2020
Q1
Sell
-2,290
Closed -$203K 127
2019
Q4
$203K Buy
+2,290
New +$203K 0.14% 139
2019
Q3
Sell
-8,295
Closed -$603K 147
2019
Q2
$603K Buy
8,295
+853
+11% +$62K 0.43% 64
2019
Q1
$600K Sell
7,442
-76
-1% -$6.13K 0.43% 65
2018
Q4
$693K Buy
+7,518
New +$693K 0.58% 56
2018
Q3
Sell
-7,759
Closed -$719K 120
2018
Q2
$719K Sell
7,759
-214
-3% -$19.8K 0.53% 53
2018
Q1
$755K Buy
7,973
+2,123
+36% +$201K 0.56% 55
2017
Q4
$566K Buy
5,850
+67
+1% +$6.48K 0.42% 65
2017
Q3
$514K Buy
5,783
+57
+1% +$5.07K 0.44% 64
2017
Q2
$415K Buy
5,726
+116
+2% +$8.41K 0.38% 69
2017
Q1
$366K Sell
5,610
-441
-7% -$28.8K 0.35% 76
2016
Q4
$379K Sell
6,051
-8,914
-60% -$558K 0.37% 74
2016
Q3
$944K Buy
+14,965
New +$944K 0.53% 64
2016
Q2
Sell
-11,152
Closed -$660K 114
2016
Q1
$660K Buy
+11,152
New +$660K 0.43% 72